CREDIT SUISSE AG/ - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$13,000
-78.3%
18,331
-41.3%
0.00%
Q3 2018$60,000
-80.6%
31,247
-42.9%
0.00%
Q2 2018$310,000
+23.5%
54,759
-7.9%
0.00%
Q1 2018$251,000
+14.1%
59,436
+44.6%
0.00%
Q4 2017$220,000
-42.0%
41,093
-51.6%
0.00%
Q3 2017$379,000
+77.9%
84,964
+93.8%
0.00%
Q2 2017$213,000
-42.4%
43,838
-14.2%
0.00%
Q1 2017$370,000
-74.1%
51,072
-79.5%
0.00%
-100.0%
Q4 2016$1,429,000
+71.3%
249,690
+283.3%
0.00%0.0%
Q3 2016$834,000
-36.4%
65,135
-38.2%
0.00%0.0%
Q2 2016$1,312,000
+151.3%
105,349
+68.8%
0.00%0.0%
Q1 2016$522,000
+20.0%
62,403
+41.9%
0.00%
Q4 2015$435,000
-9.4%
43,992
+12.3%
0.00%
-100.0%
Q3 2015$480,000
-47.3%
39,167
-34.1%
0.00%0.0%
Q2 2015$911,000
+39.7%
59,451
+55.8%
0.00%0.0%
Q1 2015$652,000
+10.3%
38,165
-1.4%
0.00%0.0%
Q4 2014$591,000
-45.6%
38,707
-62.2%
0.00%0.0%
Q3 2014$1,086,000
-14.6%
102,472
+22.5%
0.00%0.0%
Q2 2014$1,272,000
-31.0%
83,631
-41.6%
0.00%
-50.0%
Q1 2014$1,843,000
+119.9%
143,180
+198.0%
0.00%
+100.0%
Q4 2013$838,000
+123.5%
48,050
+107.0%
0.00%
Q3 2013$375,000
-70.8%
23,208
-76.0%
0.00%
-100.0%
Q2 2013$1,284,000
+1.3%
96,674
+23.1%
0.00%0.0%
Q1 2013$1,268,00078,5320.00%
Other shareholders
ENDOLOGIX INC shareholders Q4 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,121,447$5,450,0002.37%
Essex Woodlands Management, Inc. 1,257,468$11,699,0002.12%
Redmile Group, LLC 6,368,299$30,950,0001.88%
Camber Capital Management LP 7,500,000$36,450,0001.78%
Sio Capital Management, LLC 493,060$2,396,0001.14%
Rhenman & Partners Asset Management AB 1,575,000$7,655,0001.10%
PFM Health Sciences, LP 5,599,466$27,213,0000.73%
Elk Creek Partners, LLC 2,087,238$10,144,0000.66%
Partner Investment Management, L.P. 99,736$485,0000.65%
Brown Capital Management 8,783,162$42,686,0000.52%
View complete list of ENDOLOGIX INC shareholders